论文部分内容阅读
目的:研究疏血通注射液联合尿激酶对血液灌流期间下肢深静脉血栓形成的治疗效果。方法:选择2013年4月至2015年7月该院收治的68例血流灌流期间下肢深静脉形成患者作为研究病例,将其分成实验组和对照组各34例,其中对照组患者使用尿激酶和低分子肝素钙治疗,实验组以此为基础再用疏血通注射液治疗,对比两组治疗效果。结果:实验组治疗总有效率为94.1%,对照组总有效率为76.5%,两组治疗效果比较,具有统计学意义(P<0.05)。结论:联合应用疏血通注射液和尿激酶治疗血液灌流期间下肢深静脉血栓形成,效果明显,建议应用。
Objective: To study the therapeutic effect of Shuxuetong injection combined with urokinase on deep vein thrombosis during hemoperfusion. Methods: From April 2013 to July 2015, 68 patients with deep venous lower limbs formed during perfusion in our hospital were selected as study cases and divided into experimental group and control group, with 34 cases in each group. The patients in control group were treated with urokinase And low molecular weight heparin calcium treatment, the experimental group and then Shuxuetong injection treatment, the two groups compared the therapeutic effect. Results: The total effective rate was 94.1% in the experimental group and 76.5% in the control group. There was significant difference between the two groups (P <0.05). Conclusion: The combination of Shuxuetong injection and urokinase in the treatment of hemoperfusion deep vein thrombosis, the effect is obvious, it is recommended.